Evidence map›Paper›PMID 22232556›Full record

ArticleThe Journal of biological chemistry2012

Protein kinase C (PKC)ζ-mediated Gαq stimulation of ERK5 protein pathway in cardiomyocytes and cardiac fibroblasts.

Carlota García-Hoz, Guzmán Sánchez-Fernández, Ramón García-Escudero, María Fernández-Velasco, Julia Palacios-García, Marisol Ruiz-Meana, Maria Teresa Díaz-Meco, Michael Leitges, Jorge Moscat, David García-Dorado and 3 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 29 citations in OpenAlex.

  1. G protein GαThe Journal of biological chemistry · 2026
    Article
  2. Review
  3. OXTRNature communications · 2022
    Article
  4. Review
  5. Article
  6. Article
  7. PKC and PKN in heart disease.Journal of molecular and cellular cardiology · 2019
    Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 10 institutions in 3 countries.

Carlota García-HozDepartamento de Biología Molecular and Centro de Biología Molecular Severo Ochoa, Consejo Superior de Investigaciones Científicas-Universidad Autónoma de Madrid (CSIC-UAM), 28049 Madrid, Universidad Autónoma de Madrid, Spain.
Guzmán Sánchez-Fernández
Ramón García-Escudero
María Fernández-Velasco
Julia Palacios-García
Marisol Ruiz-Meana
Maria Teresa Díaz-Meco
Michael Leitges
Jorge Moscat
David García-Dorado
Lisardo Boscá
Federico Mayor
Catalina Ribas
Consejo Superior de Investigaciones Científicas · ESSanford Burnham Prebys Medical Discovery Institute · USUniversitat Autònoma de Barcelona · ESCentro de Biología Molecular Severo Ochoa · ESCentro de Investigaciones Energéticas, Medioambientales y Tecnológicas · ESHospital La Paz Institute for Health Research · ESHospital Universitario de La Princesa · ESInstituto de Investigaciones Biomédicas Sols-Morreale · ESUniversidad Autónoma de Madrid · ESUniversity of Oslo · NO

Funding

The Par-4/PKCz complex in prostate cancerR01CA134530 · NCI · UNIVERSITY OF CINCINNATI · PI DIAZ MECO CONDE, MARIA TERESA · 2009 to 2013
$1.8M
NCI NIH HHS R01 CA134530
6 · The paper itself

Abstract

Gq-coupled G protein-coupled receptors (GPCRs) mediate the actions of a variety of messengers that are key regulators of cardiovascular function. Enhanced Gα(q)-mediated signaling plays an important role in cardiac hypertrophy and in the transition to heart failure. We have recently described that Gα(q) acts as an adaptor protein that facilitates PKCζ-mediated activation of ERK5 in epithelial cells. Because the ERK5 cascade is known to be involved in cardiac hypertrophy, we have investigated the potential relevance of this pathway in cardiovascular Gq-dependent signaling using both cultured cardiac cell types and chronic administration of angiotensin II in mice. We find that PKCζ is required for the activation of the ERK5 pathway by Gq-coupled GPCR in neonatal and adult murine cardiomyocyte cultures and in cardiac fibroblasts. Stimulation of ERK5 by angiotensin II is blocked upon pharmacological inhibition or siRNA-mediated silencing of PKCζ in primary cultures of cardiac cells and in neonatal cardiomyocytes isolated from PKCζ-deficient mice. Moreover, upon chronic challenge with angiotensin II, these mice fail to promote the changes in the ERK5 pathway, in gene expression patterns, and in hypertrophic markers observed in wild-type animals. Taken together, our results show that PKCζ is essential for Gq-dependent ERK5 activation in cardiomyocytes and cardiac fibroblasts and indicate a key cardiac physiological role for the Gα(q)/PKCζ/ERK5 signaling axis.

Indexed as

Angiotensin IIAnimalsCells, CulturedEnzyme ActivationFibroblastsGTP-Binding Protein alpha Subunits, Gq-G11MAP Kinase Signaling SystemMiceMice, Mutant StrainsMitogen-Activated Protein Kinase 7MyocardiumMyocytes, CardiacProtein Kinase C-epsilonVasoconstrictor AgentsAngiotensin IIGTP-Binding Protein alpha Subunits, Gq-G11Mitogen-Activated Protein Kinase 7Protein Kinase C-epsilonVasoconstrictor Agents

Identifiers

PMID22232556
PMCPMC3293562
OpenAlexW2072547862

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.